Your browser doesn't support javascript.
loading
Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma.
Cabeza-Segura, Manuel; Gambardella, Valentina; Gimeno-Valiente, Francisco; Carbonell-Asins, Juan Antonio; Alarcón-Molero, Lorena; González-Vilanova, Arturo; Zuñiga-Trejos, Sheila; Rentero-Garrido, Pilar; Villagrasa, Rosana; Gil, Mireia; Durá, Ana; Richart, Paula; Alonso, Noelia; Huerta, Marisol; Roselló, Susana; Roda, Desamparados; Tarazona, Noelia; Martínez-Ciarpaglini, Carolina; Castillo, Josefa; Cervantes, Andrés; Fleitas, Tania.
Afiliación
  • Cabeza-Segura M; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Gambardella V; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Gimeno-Valiente F; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
  • Carbonell-Asins JA; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Alarcón-Molero L; Cancer Evolution and Genome Instability Laboratory, UCL Cancer Institute, London, UK.
  • González-Vilanova A; Department of Bioinformatics and Biostatistics. INCLIVA, Biomedical Research Institute, Valencia, Spain.
  • Zuñiga-Trejos S; Department of Pathology, INCLIVA, Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Rentero-Garrido P; Department of Bioinformatics and Biostatistics. INCLIVA, Biomedical Research Institute, Valencia, Spain.
  • Villagrasa R; Department of Bioinformatics and Biostatistics. INCLIVA, Biomedical Research Institute, Valencia, Spain.
  • Gil M; Department of Precision Medicine, INCLIVA, Biomedical Research Institute, Valencia, Spain.
  • Durá A; Department of Gastroenterology and Hepatology, Hospital Clínico Universitario de Valencia, Valencia, Spain.
  • Richart P; Department of Medical Oncology, Hospital General Universitario, Valencia, Spain.
  • Alonso N; Department of Gastroenterology and Hepatology, Hospital General Universitario, Valencia, Spain.
  • Huerta M; Department of Medical Oncology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Roselló S; Department of Gastroenterology and Hepatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Roda D; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Tarazona N; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Martínez-Ciarpaglini C; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
  • Castillo J; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Cervantes A; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
  • Fleitas T; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Valencia, Spain.
Br J Cancer ; 127(12): 2198-2206, 2022 12.
Article en En | MEDLINE | ID: mdl-36253523
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas Tipo de estudio: Prognostic_studies Idioma: En Revista: Br J Cancer Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas Tipo de estudio: Prognostic_studies Idioma: En Revista: Br J Cancer Año: 2022 Tipo del documento: Article